Trial Profile
Competence Network - Dementia (BMBF) "Pharmacological and Psychosocial Treatment" (Modul E.2) Part II: The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2022
Price :
$35
*
At a glance
- Drugs Galantamine (Primary) ; Memantine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms AD-Combi
- 20 Aug 2013 New trial record